| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 50 |
| 1 | ASPIRIN 325 MG | 50 |
| 2 | ASPIRIN 81 MG | 50 |
| 3 | APIXABAN | 47 |
| 4 | FUROSEMIDE | 46 |
| 5 | CLOPIDOGREL | 37 |
| 6 | RIVAROXABAN | 35 |
| 7 | BISOPROLOL FUMARATE | 34 |
| 8 | DABIGATRAN ETEXILATE | 30 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANDEXANET ALFA | 3 | 0.0042 |
| 1 | BUTORPHANOL TARTRATE | 1 | 0.0030 |
| 2 | IDARUCIZUMAB | 4 | 0.0028 |
| 3 | CANGRELOR | 1 | 0.0025 |
| 4 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 5 | FLUMAZENIL | 2 | 0.0023 |
| 6 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 7 | CEFUROXIME SODIUM | 2 | 0.0016 |
| 8 | CANDIDA ALBICANS | 1 | 0.0016 |
| 9 | SITAGLIPTIN PHOSPHATE | 4 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 1 | Factor Xa Inhibitor [EPC] | 82 |
| 2 | Proton Pump Inhibitor [EPC] | 53 |
| 3 | Loop Diuretic [EPC] | 52 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 51 |
| 5 | Atypical Antipsychotic [EPC] | 38 |
| 6 | Benzodiazepine [EPC] | 38 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 38 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 36 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 1 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 2 | Skin Test Antigen [EPC] | 2 | 0.0011 |
| 3 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 4 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 5 | Bismuth [EPC] | 3 | 0.0005 |
| 6 | Antifibrinolytic Agent [EPC] | 5 | 0.0005 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 8 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 9 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |